Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation is a research paper published in The EMBO Journal (2021). On theSindex it has a DataRank of 2.0. It has been cited 64 times, with 55 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.626
From this paper's citation signal
Citation Network Contribution
1.4
From 50 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 55 citers.
HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K08AR068619
HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR076013
National Research Foundation of Korea
Grant: NRF‐2019R1A6A3A03031609
Howard Hughes Medical Institute
Grant: Medical Student Fellowship
National Institutes of Health
Grant: 5R01AR076013-04
Immunotherapy for Skin Cancer Precursors to Prevent Skin Cancer
National Institutes of Health
Grant: 5K08AR068619-06
The Role of Allergic Contact Dermatitis in Skin Carcinogenesis
Howard Hughes Medical Institute
Sidney Kimmel Foundation
Burroughs Wellcome Fund
Howard Hughes Medical Institute
FWCI
3.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals